Skip to main content
TipRanks
Go Ultimate75% OFF

Vitalhub (VHIBF) Stock Price & Analysis

2 Followers

VHIBF Stock Chart & Stats

$4.58-$0.03(-0.72%)
At close: 4:00 PM EST
$4.5$5$5.5$6Aug 24Sep 8Sep 17Oct 5Oct 19Nov 2Nov 16
Day’s Range
$4.58 - $4.79
52-Week Range
$4.57 - $7.06
Previous Close
$4.61
Volume
N/A
Average Volume (3M)
23.00K
Market Cap
$310.99M
Enterprise Value
$359.75M
Total Cash (Recent Filing)
$129.01M
Total Debt (Recent Filing)
$3.22M
Price to Earnings (P/E)
40.2
Beta
0.90
Next Earnings
Mar 31, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Recurring Revenue Growth

Strong ARR and recurring-revenue growth supports greater visibility than project-based sales alone. A larger contracted revenue base can improve retention economics, stabilize planning, and provide a durable platform for cross-selling additional healthcare workflow and care-coordination products.

Margin Improvement

The higher adjusted EBITDA margin indicates meaningful operating leverage and improving profitability as Vitalhub integrates acquisitions and manages development spending. Sustaining this margin would strengthen internal funding capacity and make future growth less dependent on external capital.

Debt-Free Balance Sheet

A debt-free balance sheet with substantial cash gives Vitalhub financial flexibility to absorb operating variability, invest in its software platform, and pursue complementary acquisitions. Low leverage also reduces interest burden and preserves strategic options through changing healthcare technology conditions.

Bears Say

SHREWD Customer Uncertainty

The SHREWD situation creates a material risk to recurring revenue durability because management cannot yet determine which accounts may be affected. Continued suspensions or reversals could reduce ARR, delay growth recovery, and require the broader portfolio to offset a meaningful product-specific shortfall.

Revenue Growth Slowdown

The recent revenue slowdown challenges the durability of Vitalhub's earlier growth trajectory, even as recurring revenue expands. Flat total revenue and weaker variable revenue can limit near-term operating leverage, complicate forecasting, and increase reliance on successful renewals, integrations, and new bookings.

Attend Anywhere Decline

A potential continuing decline in Attend Anywhere represents a structural product-level headwind within the portfolio. Even if other offerings offset part of the reduction, lower renewals or usage can weigh on recurring revenue, reduce cross-product momentum, and increase the execution burden on newer growth initiatives.

Vitalhub News

VHIBF FAQ

What was Vitalhub’s price range in the past 12 months?
Vitalhub lowest stock price was $4.57 and its highest was $7.06 in the past 12 months.
What is Vitalhub’s market cap?
Vitalhub’s market cap is $310.99M.
When is Vitalhub’s upcoming earnings report date?
Vitalhub’s next earnings report is estimated for Mar 31, 2027 (not yet confirmed), which is in 134 days.
How were Vitalhub’s earnings last quarter?
Vitalhub released its earnings results on Nov 12, 2026. The company reported $0.028 earnings per share for the quarter, missing the consensus estimate of $0.046 by -$0.018.
Is Vitalhub overvalued?
According to Wall Street analysts Vitalhub’s price is currently Undervalued.
Does Vitalhub pay dividends?
Vitalhub does not currently pay dividends.
What is Vitalhub’s EPS estimate?
Vitalhub’s EPS estimate is 0.04.
How many shares outstanding does Vitalhub have?
Vitalhub has 63,414,160 shares outstanding.
What happened to Vitalhub’s price movement after its last earnings report?
Vitalhub reported an EPS of $0.028 in its last earnings report, missing expectations of $0.046. Following the earnings report the stock price went down -17.708%.
Which hedge fund is a major shareholder of Vitalhub?
Currently, no hedge funds are holding shares in VHIBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology